Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
A Randomized, Single (Operator)-Blinded, Controlled Clinical Study for Assessing Major Symptoms and Function in Patients With Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis Who Switch From Combustible Cigarettes (CIG) to Tobacco Heating System (THS)
Philip Morris Products S.A.
290 participants
Apr 2, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this randomized study is to demonstrate direct clinical benefit, i.e., observed benefits in how humans with COPD feel in terms of symptoms (e.g., cough frequency, shortness of breath, and other respiratory symptoms) and function (e.g., lung function, and six-minute walking test \[6MWT\]) after switching to THS compared to continuing to smoking cigarettes.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
COPD patients will continue to smoke their cigarettes ad libitum, with no brand restrictions.
COPD patients will switch from cigarette smoking to ad libitum THS use, with no flavor variant restrictions.
Locations(111)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07108166